TABLE 2.

Description of plans used for the training dataset

Plan number	Tumor site	Dose per fraction (Gy)	Number of beams	Average number of segments per beam	Dose point prescription (MUs/Gy)	Plan MCS	Average γ‐passing rate c (%)	Number of beams used
1	H&N a	0.140	7	9	289.20	0.67	98.63	5
2	H&N a	0.142	7	13	420.49	0.47	97.59	5
3	H&N a	0.058	7	5	256.77	0.57	99.35	7
4	Prostate	0.054	7	6	252.43	0.70	98.99	6
5	Prostate	0.109	7	14	347.67	0.49	99.19	6
6	Prostate	0.158	7	7	198.68	0.66	98.88	6
7	Prostate	0.109	7	14	374.38	0.48	97.99	7
8	H&N a	0.062	6	8	254.37	0.56	98.47	5
9	Stomach	0.074	7	8	328.19	0.49	98.75	6
10	Lungs	0.070	5	10	450.10	0.54	99.46	4
11	Breast	0.080	2	3	98.69	N.A. b	99.68	2
12	H&N a	0.083	5	7	180.97	0.73	99.27	5
13	Lungs	0.062	6	9	275.43	0.65	98.45	6
14	H&N a	0.083	6	9	1267.11	0.63	98.94	6
15	Kidney	0.318	7	5	177.75	0.73	99.49	7
16	Brain	0.055	6	5	208.83	0.63	98.09	5
17	Prostate	0.189	6	8	325.79	0.73	99.42	6
18	H&N a	0.119	7	14	515.25	0.44	98.82	7
19	Prostate	0.060	7	7	262.91	0.66	99.31	5
20	H&N	0.063	5	7	185.18	0.63	99.27	4
21	H&N a	0.137	5	7	207.39	0.70	99.00	4
22	Mediastinum	0.061	7	7	890.04	0.64	98.79	6
23	H&N a	0.139	5	9	230.67	0.71	98.65	4
24	Lungs	0.116	7	4	171.74	0.70	99.01	3
25	H&N a	0.207	5	11	217.35	0.68	97.80	3
26	Prostate	0.090	7	8	259.73	0.55	98.79	7
27	H&N a	0.139	7	6	171.51	0.71	98.46	7
28	Breast	0.079	2	4	107.77	0.00	99.55	1
29	Brain	0.188	7	8	197.93	0.67	98.68	6
30	Prostate	0.056	7	6	309.44	0.69	98.81	6
31	H&N a	0.077	5	7	505.42	0.68	98.45	4
32	Rectum	1.055	5	19	247.43	0.60	99.14	4
33	H&N a	0.144	7	13	386.35	0.45	98.10	6
34	Prostate	0.155	7	8	195.62	0.73	99.25	5
35	Stomach	0.073	7	8	338.63	0.51	99.22	5
36	Rectum	0.082	7	8	276.41	0.55	99.50	5

^a Head and Neck tumor site

^b Non‐Applicable values of MCS score ⁴⁹ are caused by a specific case where all MLC leaves of a bank are aligned

^c The average γ‐passing rate is computed on all beams of the plan with the criteria of 2%‐2 mm >10% D_max.